Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
Authors
Keywords
-
Journal
PEDIATRIC HEMATOLOGY AND ONCOLOGY
Volume 34, Issue 3, Pages 165-185
Publisher
Informa UK Limited
Online
2017-06-30
DOI
10.1080/08880018.2017.1330375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma
- (2016) Marie Regairaz et al. AMERICAN JOURNAL OF PATHOLOGY
- Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
- (2016) Cecilia Dyberg et al. BMC CANCER
- Factors associated with recurrence and survival length following relapse in patients with neuroblastoma
- (2016) Nermine O Basta et al. BRITISH JOURNAL OF CANCER
- High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients
- (2016) Patrick Y. Kim et al. CANCER LETTERS
- Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway
- (2016) Afzal Sheikh et al. CANCER SCIENCE
- Genetic discoveries and treatment advances in neuroblastoma
- (2016) Rochelle Bagatell et al. CURRENT OPINION IN PEDIATRICS
- Risk stratification and therapeutics of neuroblastoma: the challenges remain
- (2016) Hong Mei et al. World Journal of Pediatrics
- XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis
- (2016) Zhang'e Choo et al. Oncotarget
- Involvement of IL-10 and TGF-β in HLA-E-mediated neuroblastoma migration and invasion
- (2016) Zijun Zhen et al. Oncotarget
- Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma
- (2016) Saurabh Agarwal et al. Oncotarget
- Association of microRNA 21 with Biological Features and Prognosis of Neuroblastoma
- (2016) Yaodong Zhou et al. Cancer Control
- Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
- (2016) Na Hee Lee et al. Cancer Research and Treatment
- Diagnostic Utility of PHOX2B in Primary and Treated Neuroblastoma and in Neuroblastoma Metastatic to the Bone Marrow
- (2015) Jessica L. Hata et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study
- (2015) L L Wang et al. BRITISH JOURNAL OF CANCER
- Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
- (2015) Kristopher R. Bosse et al. CANCER
- Identification of patient subgroups with markedly disparate rates ofMYCNamplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project
- (2015) Daria Thompson et al. CANCER
- The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients
- (2015) A. Bartolini et al. CANCER RESEARCH
- Telomere maintenance is pivotal for high-risk neuroblastoma
- (2015) Falk Hertwig et al. CELL CYCLE
- High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas
- (2015) Pramila Ramani et al. JOURNAL OF NEURO-ONCOLOGY
- Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors
- (2015) Sho Kurihara et al. JOURNAL OF PEDIATRIC SURGERY
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
- (2015) Linda J Valentijn et al. NATURE GENETICS
- The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
- (2015) F Amoroso et al. ONCOGENE
- Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach
- (2015) Kohei Otake et al. PEDIATRIC BLOOD & CANCER
- Neuroblastoma
- (2015) Meredith S. Irwin et al. PEDIATRIC CLINICS OF NORTH AMERICA
- High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas
- (2015) Pramila Ramani et al. VIRCHOWS ARCHIV
- Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
- (2015) S Nicolai et al. Cell Death & Disease
- Identification of GALNT14 as a novel neuroblastoma predisposition gene
- (2015) Marilena De Mariano et al. Oncotarget
- PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions
- (2015) Rosa Gómez-Villafuertes et al. Scientific Reports
- Expression ofFOXP3,CD14, andARG1in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
- (2015) Sara Stigliani et al. Biomed Research International
- Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
- (2015) Giselle L. Saulnier Sholler et al. Cancer Medicine
- Detection of tumorALKstatus in neuroblastoma patients using peripheral blood
- (2015) Valérie Combaret et al. Cancer Medicine
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma
- (2014) Jessica Theissen et al. GENES CHROMOSOMES & CANCER
- Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group Database
- (2014) Daniel A. Morgenstern et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2014) Kieuhoa T. Vo et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical features of ATRX or DAXX mutated neuroblastoma
- (2014) Sho Kurihara et al. JOURNAL OF PEDIATRIC SURGERY
- Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance
- (2014) M Czarnecka et al. ONCOGENE
- CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients
- (2014) Ali Rihani et al. PLoS One
- TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival
- (2014) P L Chavali et al. Cell Death & Disease
- Unlikely Suspects Identified in Neuroblastoma Conspiracy
- (2014) R. Bernards Cancer Discovery
- Determination of catecholamines in plasma and urine
- (2013) Eric Grouzmann et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group
- (2013) Larry L. Wang et al. CANCER
- Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study
- (2013) J. Osman et al. Clinical & Translational Oncology
- ALK amplification and protein expression predict inferior prognosis in neuroblastomas
- (2013) Miao Wang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group
- (2013) G. A. Yanik et al. JOURNAL OF NUCLEAR MEDICINE
- Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project
- (2013) Yaël P. Mossé et al. PEDIATRIC BLOOD & CANCER
- Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas
- (2013) N. Ikegaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
- (2012) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors
- (2012) Peter E. Zage et al. CANCER
- VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours
- (2012) Pramila Ramani et al. HISTOPATHOLOGY
- CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
- (2012) Hervé Sartelet et al. HISTOPATHOLOGY
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
- (2012) Rie Suganuma et al. PEDIATRIC BLOOD & CANCER
- High Anaplastic Lymphoma Kinase Immunohistochemical Staining in Neuroblastoma and Ganglioneuroblastoma Is an Independent Predictor of Poor Outcome
- (2011) Floor A.M. Duijkers et al. AMERICAN JOURNAL OF PATHOLOGY
- Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
- (2011) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG project
- (2011) Paola Angelini et al. EUROPEAN JOURNAL OF CANCER
- ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome
- (2011) Franck Bourdeaut et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
- (2011) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors
- (2011) Mi Jung Kwon et al. PATHOLOGY RESEARCH AND PRACTICE
- Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
- (2011) Hervé J. Brisse et al. RADIOLOGY
- The MYCN oncogene and differentiation in neuroblastoma
- (2011) Ulrica K. Westermark et al. SEMINARS IN CANCER BIOLOGY
- Emerging importance of ALK in neuroblastoma
- (2011) Anna M. Azarova et al. SEMINARS IN CANCER BIOLOGY
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
- (2011) Lễ B. Nguyễn et al. PLoS Genetics
- NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome
- (2010) Michael Hölzel et al. CELL
- Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma
- (2010) P. G. Buckley et al. CLINICAL CANCER RESEARCH
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2010) Julie R. Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Birth weight and risk of neuroblastoma: a meta-analysis
- (2010) T. Harder et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma
- (2010) Stefano Parodi et al. PEDIATRIC BLOOD & CANCER
- Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005
- (2010) Kelsey A. Johnson et al. PEDIATRIC BLOOD & CANCER
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomas
- (2009) Manish Mani Subramaniam et al. HUMAN PATHOLOGY
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Poor Survival for Infants WithMYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
- (2009) Adela Canete et al. JOURNAL OF CLINICAL ONCOLOGY
- 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
- (2009) S. E. Sharp et al. JOURNAL OF NUCLEAR MEDICINE
- Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
- (2009) Hilde Brems et al. LANCET ONCOLOGY
- Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma
- (2009) S. A. Vasudevan et al. MOLECULAR CANCER THERAPEUTICS
- High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours
- (2008) Helena Carén et al. BIOCHEMICAL JOURNAL
- High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene
- (2008) Helena Caren et al. BMC GENOMICS
- Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis
- (2008) W.-M. Hsu et al. CLINICAL CANCER RESEARCH
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- Significance ofMYCNAmplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database
- (2008) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search